Nirk E. Quispe Calla

Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection

Nirk E. Quispe Calla, Rodolfo D. Vicetti Miguel, Prosper N. Boyaka et al. · Mucosal Immunology · 2016 · 83 citations · Full text

Medroxyprogesterone Acetate, Hormonal Contraceptive, Vaginitis +5

Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage

Rodolfo D. Vicetti Miguel, Nirk E. Quispe Calla, Stephen D. Pavelko et al. · PLoS ONE · 2016 · 49 citations · Full text

IL-4–secreting eosinophils promote endometrial stromal cell proliferation and prevent <i>Chlamydia</i> -induced upper genital tract damage

Rodolfo D. Vicetti Miguel, Nirk E. Quispe Calla, Darlene Dixon et al. · Proceedings of the National Academy of Sciences · 2017 · 42 citations · Full text

Medroxyprogesterone acetate impairs human dendritic cell activation and function

Nirk E. Quispe Calla, Mohammed G. Ghonime, Thomas L. Cherpes et al. · Human Reproduction · 2015 · 25 citations · Full text

Depot-medroxyprogesterone acetate reduces genital cell–cell adhesion molecule expression and increases genital herpes simplex virus type 2 infection susceptibility in a dose-dependent fashion

Nirk E. Quispe Calla, Rodolfo D. Vicetti Miguel, Kristen M. Aceves et al. · Contraception · 2019 · 22 citations · Full text

Depot-medroxyprogesterone Acetate Reduces, Translational Medicine, Hormonal Contraceptive +6